Kwon Yang Woo, Jo Han-Seul, Bae Sungwon, Seo Youngsuk, Song Parkyong, Song Minseok, Yoon Jong Hyuk
Neurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu, South Korea.
Department of Convergence Medicine, Pusan National University School of Medicine, Yangsan, South Korea.
Front Med (Lausanne). 2021 Sep 22;8:747333. doi: 10.3389/fmed.2021.747333. eCollection 2021.
Proteomics has become an important field in molecular sciences, as it provides valuable information on the identity, expression levels, and modification of proteins. For example, cancer proteomics unraveled key information in mechanistic studies on tumor growth and metastasis, which has contributed to the identification of clinically applicable biomarkers as well as therapeutic targets. Several cancer proteome databases have been established and are being shared worldwide. Importantly, the integration of proteomics studies with other omics is providing extensive data related to molecular mechanisms and target modulators. These data may be analyzed and processed through bioinformatic pipelines to obtain useful information. The purpose of this review is to provide an overview of cancer proteomics and recent advances in proteomic techniques. In particular, we aim to offer insights into current proteomics studies of brain cancer, in which proteomic applications are in a relatively early stage. This review covers applications of proteomics from the discovery of biomarkers to the characterization of molecular mechanisms through advances in technology. Moreover, it addresses global trends in proteomics approaches for translational research. As a core method in translational research, the continued development of this field is expected to provide valuable information at a scale beyond that previously seen.
蛋白质组学已成为分子科学中的一个重要领域,因为它能提供有关蛋白质的身份、表达水平和修饰的有价值信息。例如,癌症蛋白质组学在肿瘤生长和转移的机制研究中揭示了关键信息,这有助于识别临床适用的生物标志物以及治疗靶点。多个癌症蛋白质组数据库已经建立并在全球范围内共享。重要的是,蛋白质组学研究与其他组学的整合正在提供与分子机制和靶点调节剂相关的大量数据。这些数据可通过生物信息学管道进行分析和处理,以获得有用信息。本综述的目的是概述癌症蛋白质组学以及蛋白质组学技术的最新进展。特别是,我们旨在深入了解目前脑癌的蛋白质组学研究,其中蛋白质组学应用尚处于相对早期阶段。本综述涵盖了蛋白质组学从生物标志物发现到通过技术进步对分子机制进行表征的应用。此外,它还探讨了蛋白质组学方法在转化研究中的全球趋势。作为转化研究的核心方法,预计该领域的持续发展将以前所未有的规模提供有价值的信息。